Henry Schein (HSIC)
Distributes clinical supplies and equipment alongside specialty products and practice software.
$86.12
vs last close−1.31 (−1.50%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3,162 | 3,017 | 3,172 | 3,136 | 3,174 | 3,191 | 3,168 | 3,240 | 3,339 | 3,437 | 3,368 | 3,458 |
| Cost of revenue | 2,226 | 2,150 | 2,221 | 2,181 | 2,245 | 2,261 | 2,230 | 2,288 | 2,381 | 2,443 | 2,298 | 2,357 |
| Gross profit | 936 | 867 | 951 | 955 | 929 | 930 | 938 | 952 | 958 | 994 | 1,070 | 1,101 |
| 725 | 807 | 791 | 781 | 724 | 738 | 736 | 777 | 752 | 808 | 888 | 901 | |
| Selling, general & administrative | 725 | 807 | 791 | 781 | 724 | 738 | 736 | 777 | 752 | 808 | 809 | 831 |
| Other expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 79 | 70 |
| Operating income | 211 | 60 | 160 | 174 | 205 | 192 | 202 | 175 | 206 | 186 | 182 | 200 |
| −29 | −42 | −30 | −36 | −74 | −65 | −54 | −50 | −69 | −51 | −32 | −64 | |
| Interest income | 6 | 5 | 5 | 6 | 7 | 6 | 6 | 9 | 9 | 9 | 7 | 8 |
| Interest expense | 25 | 29 | 30 | 32 | 34 | 35 | 35 | 38 | 38 | 39 | 39 | 43 |
| Other non-operating income | 7 | 17 | 3 | 10 | 43 | 31 | 22 | 16 | 31 | 12 | −7 | 20 |
| Income before tax | 182 | 18 | 130 | 138 | 131 | 127 | 148 | 125 | 137 | 135 | 150 | 136 |
| Income tax expense | 39 | 1 | 32 | 33 | 32 | 31 | 35 | 31 | 28 | 32 | 38 | 34 |
| Net income from continuing operations | 143 | 17 | 98 | 105 | 99 | 96 | 113 | 94 | 109 | 103 | 112 | 102 |
| Net income | 137 | 18 | 93 | 104 | 99 | 94 | 110 | 86 | 101 | 101 | 107 | 94 |
| EPS, basic | $1.05 | $0.14 | $0.72 | $0.81 | $0.79 | $0.75 | $0.89 | $0.71 | $0.84 | $0.86 | $0.93 | $0.83 |
| EPS, diluted | $1.05 | $0.14 | $0.72 | $0.80 | $0.78 | $0.74 | $0.88 | $0.70 | $0.84 | $0.85 | $0.92 | $0.82 |
| Weighted average shares, basic | 130 | 130 | 129 | 128 | 126 | 125 | 124 | 122 | 120 | 117 | 115 | 113 |
| Weighted average shares, diluted | 131 | 131 | 130 | 129 | 127 | 126 | 125 | 123 | 121 | 118 | 116 | 114 |
| EBITDA | 273 | 111 | 230 | 238 | 236 | 237 | 253 | 235 | 255 | 256 | 256 | 264 |
| Depreciation & amortization | 69 | 68 | 73 | 74 | 74 | 76 | 73 | 76 | 80 | 82 | 67 | 84 |
| EBIT | 204 | 43 | 157 | 164 | 162 | 161 | 180 | 159 | 175 | 174 | 189 | 180 |
